Deflazacort Tablet 6Mg is immunosuppressant which is indicated for the treatment of asthma, rheumatoid arthritis, Crohn's disease, and multiple myeloma. The active compound of this medicine has molecular formula C25H31NO6 with a molar mass of 441.517 g/mol and elimination half-life of about 1.1 to 1.9 hours of its metabolite. Upon ingestion, it gets metabolized by plasma esterases with protein binding ability of about 40%. This tablet belongs to the glucocorticoid class of drugs and is also known to possess anti-inflammatory property. Deflazacort Tablet 6Mg is also prescribed for ulcerative colitis, muscular dystrophy, and autoimmune hemolytic anemia. It is highly effective in nature and assures targeted mode of action.